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In vitro angiogenesis models suggest that new blood 
vessel formation requires the induction and secretion 
by endothelial cells of matrix metalloproteinases. 
These enzymes assist in the controlled proteolytic 
degradation of the surrounding extracellular matrix 
during blood vessel formation. The results of in 11itro 
studies cannot be extrapolated directly to the process 
o£ iu vivo angiogenesis because the type of matrix 
employed and the repertoire of enzymes secreted by 
" cells in 11ivo differ dramatically from iu vivo condi-
tions. To investigate the itt vivo role of matrix metal-
loproteinases in blood vessel development, we looked 
£or the presence of these proteinases in endothelial 
cells involved in fetal angiogenesis and in neovascu-
larization of certain invasive skin tumors using im-
munofluorescent staining. In fetal tissue, interstitial 
collagenase was present in both early microvessels 
T he matrix metalloproteinases (MMPs) are a fam.ily of closely related secreted enzymes essential for the degradation .of extracellular matrix (ECM) macro-molecules. T h ese metailoproteinases play a major role in connective tissue remodeling in embryonic 
development, wound repair [1], ;u1d in certain pathologic processes 
such as tumor invasion and metastasis [2]. Although much is known 
about the action of these enzymes from iu 11itro studies, there is only 
limited information regarding their role in viJ,o in both normal and 
pathologic states . 
The vascular system is one of the earliest organ systems to 
develop in the rapidly growing embryo. Similarly, neovasculariza-
tion is essential for tumor maintenance and growth . Results of 
experiments using model systems of in 1itro angiogenesis suggest 
that controlled degradation ofECM components by MMPs secreted 
by capillary endothelial cells is a prerequisite for angiogenesis [3-7]. 
These observations are supported by the finding that an inhibitor of 
neovascularization isolated from the conditioned m edium of scap-
ular chondrocytes also inhibits mammalian collagenase (8]. In 
addition, angiogenesis induced by polyamines in yolk-sac mem-
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developing from undifferentiated mesoderm and in 
microvessels involved in elongation and sprout for-
mation from preexisting blood vessels. In aggressive 
skin tumors, i.e., morpheaform and recurrent basal 
cell carcinomas and squamous cell carcinomas, there 
was a marked increase in the number of collagenase-
containing blood vessels, often extending into the 
tumor nests. Immunofluorescent staining failed to 
detect stromelysin, matrilysin, or gelatinase A and B 
(72- and 92-kDa type IV collagenases, respectively) in 
fetal or tumor blood vessels. These findings are con-
sistent with the hypothesis that proteolytic degrada-
tion of the extracellular matrix is required for the 
formation of new blood vessels. Interstitial collage-
nase appears to play an important role in this process. 
KeJI IVords: iuterstitial collagetLase!atrgiogeuesis/morpltogeu-
esisltumorigenesis. J Invest Dumatol 105:411-417, 1995 
branes is inhibited by the tissue inhibitors of m e talloproteinases 
TIMP-1 and TIMP-2 [9]. 
Phorbol m yristate ace tate induction of endothelial cells grown on 
gels results in their invasion of the w1derlying collagen matrix to 
form an extensive network of capillary-like tubes simulating neo-
vascularization [7 ,1 OJ. Synthesis of inte rstitial collagenase , strom e-
lysin and plasminogen activator by cu ltured endothelial cells is 
markedly increased in response to phorbol m yristate acetate induc-
tion (7 ,11, 12] that may be responsible for the invasive behavior of 
these cells i11 1itro. In agreement with tllis hypothesis is the 
observation that invasion of the underlying collagen gel by these 
cells can be inhibited by metalloprotein ase inllibitors (8,13-18] . 
Similar results were obtained with cultured endothelial cells using a 
laminin-derived A-chain peptide (6] that induces activated gelati-
nase A (72-kDa type IV collagenase). An increase in urokinase-type 
plasminogen activator activity may create conditions favming the 
activation of secreted metalloproteinases such as interstitial colla-
genase, stromelysin [19 ,20], and gelatinase B (92-k:Da type IV 
collagenase) [20] , by generating plasmin from plasminogen. 
MMPs are important for endothelial cell and tumor cell invasion 
iu vi110 and i11 1itro (2, 7 ,11,12,2 1,22]. Tumor invasion assays show 
that modulation of the activity of metalloproteinases by their 
endogenous inhibitors is a etitical factor in the ability of trans-
formed cells to form tumors and to m etastasize [8,21-26] . Because 
the repertoire of MMPs secreted by cells in tissue culture diffe rs 
dramatically from that observed in tissues, and because endogenous 
metalloproteinase inllibitors can inhibit the activity of most, if not 
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all , the en zymes of this class, the role of each m e talloproteinase in 
a specifi c tissue-remodeling process remains to be defm ed. 
Here we have examined , in situ, the presence and distribution of 
secreted MMPs in endothe lial ce lls of blood vessels of feta l skin and 
oth e r fetal tissu es during embryogenesis and compared this with the 
n eovascularization that occurs in invasive skin tumors. T he results 
indicate that during development, interstitial colla genase (CT) is the 
principal MMP found in botb early microvessels develo ping from 
undifferen tiated m esenchyma.! cells and microvessels involved in 
e longation and sprout formation from preexisting blood vessels. In 
addition , CT is involved in n eovascul arization of the more aggres-
sive cutaneous tumors. 
MATERIALS AND METHODS 
All feta l material originated from medical abortions examined at 7, 10-12, 
13-16, and 22-28 weeks of gestation. The fol.lowing tissues were studied: 
skin from the trunk (n = 5) and the scalp (n = 5), lung, kidney, urinary 
bladder, stomach, colon, trachea/pharynx, and muscle (leg). T hirty tumor 
specimens, including three IJ odular basa l cell carcinomas (BCCs), five 
nodulocystic BCCs, four morpheaform (infil trative) BCCs, two keratotic 
BCCs, four adenoid BCCs, five recurrent BCCs, and seven squamous cell 
ca rcinomas (SCCs) (poorly, modera tely, and well-differentiated fonns) 
were obtained by surgical excision . Normal skin samples {n = 5) were 
obtained fro'}!_ healthy volun teers after securing informed consent. 
Specimens were embedded in Tissue-Tek O.C.T.4583 compound and 
stored at - 80°C. Seri al cryostat sections (5-7 J.Lm in thickness) were placed 
on glass slides , air dried , and fixed with 3.5% formaldehyde in Dulbecco's 
modified Eagle's phosphate-buffefed saline for 3.5 min at room tempera-
ture . T hey were then washed and incubated with the fol.lowing primary 
antibodies: affinity-purified rabbit anti-human fi broblast collagenase anti-
body and affini ty-purifi ed anti-h uman stromelysin antibody [20], a.ffinity-
purified anti-human matrilysin (pump-1 ) antibody (27 ,28], murine mono-
clonal anti-human 72-k.Da type rv collagenase (29], and affi ni ty-puri fied 
murine anti-92-k.Da type IV collagenase antibody (29]. 
T he specificity of all antibodies was shown by W estern blot analysis and 
immunoprccipitation studies (20,29]. T hese antibodies stain positively both 
cultured fib roblasts synthesizing these enzymes and sections of both normal 
tissues and tumors [20,27 ,29]. 
The following mouse monoclonal antibodies were used: FSA-a specific 
for facto r-VTII-related antigen (von WiJlebrand factor; Boehringer), NCL-
CD61 ({3-3 chain of the vitronectin receptor; Novocastra Lab) , and NCL-
CD62 (selectins PADGEM group N). These three antibodies are endothelial-
cell-specific markers. Other antibodies used were anti-human type IV collagen 
(Chemicon) and E3, a monoclonal antibody that is speciftc for cytokeratin 17 
(Sigma) . Two-step indirect immunofluorescence was used for antibodies 
against facto r-VIll-rclated antigen, NCL-CD61, NCL-CD62, type IV colla-
gen, cytokeratin 17, and matrilysin. For anti-C! and anti-92-k.Da type IV 
collagenase, a biot:U1ylated anti-rabbit complex (Sigma) was used as the second 
antibody, followed by incubation with extravidin-Auorescein isothiocyanate 
{F!TC) (Sigma). Immunoreactivity for 72-k.Da type rv collagenase was assayed 
on paraffm-embedded sections using the Vector-ABC procedure. h1cubation 
with noninunune rabbit immunoglobulin G and/or omission of the primary 
antibody served as controls. 
Double immunolabcling with monoclonal antibodies fo r factor-VIIJ-
related antigen, NCL-CD61, NCL-CD62, type IV collagen, and cytokera-
tll1 17 was performed using a tetramcthylrhodamine-isothiocyanate-conju-
gated anti-mouse antibody (Sigma). Double exposures were obtained using 
Nicon filters BA520 for FITC and BA590 for rhodamine B. The absence of 
cross-reactivity was controlled by incubation of the sections with either 
rabbit anti-C! or mouse anti-FVIII-related antigen , fo llowed by incubation 
with heterologous second antibodies (rabbit antibody fo llowed by anti-
mouse antibody and mouse antibody followed by anti-rabbi t antibody). 
Hematoxylin-stained slides of all samples were exa mined by light micros-
copy. 
RESULTS 
Fetal Skin Fetal skin was studied at 7, 10-12, 13-16, and 22-28 
weeks. At the earliest stage of gestation studied (7 weeks) , mesen-
chym al-Like cells were frequently arranged in cell clusters and short 
strands, in w bich most m esenchymal cells were C I-positive (CI+) 
(Fig 1A). Some but not all of these cr•· cells w ere also positive for 
FV!Il-related ;mtigen (FVUI +) , indica tive of endothelial cell for-
mation (Fig 1B). O nly a small population of FVIII + but collage-
nase-negative (CI - ) ce lls was observed . The m esenchymal ce Ll 
clusters most likely represent the undiffe rentiated mesodem1 re-
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sponsible for de IlO ilo blood vesse l formation (30,31]. In addition, 
cords ofFVnr•· endothelial cells that extended throughout the fe ta.I 
m esenchyme were present in the developing de rmis. CI in these 
cords was seen in an irregular linear pattem within FVIII + endo-
thelial cells. T he C I + endothe lial cells were surrounded by fine, 
fibrillar, stromal componen ts that stain ed positively for typ e IV 
collagen (not shown), indicating the early deposition of an associ-
ated basem ent membrane. 
For simplicity, we will refer only to FVIII-related antigen as the 
specific m arker for endothelial ceLls beca use the immunofluorescent 
staining pattem for the endothelial-cell-specific antigens NCL-
CD61 and N CL-CD62 para lleled that of FVIII-related antigen. 
Between 10 and 12 weeks of gestation , Cl immunoreactivity in 
the developing de rmis was present in many FV!fl + endothelial cells 
that fanned a linear array of tube-like vessels arising from m esen-
chymal ceU clusters (Fig 1C). Occasional C I+ cells present in the 
vascular tubes showed no immunostaining for FVIIT-related anti-
gen , but in all such instances an intac t type TV collagen-containing 
basement m embrane was present. [n som e areas of the ECM, 
m esenchymal cell cluste rs surrounded by type TV collagen were also 
seen. These clusters, like those seen at earlier stages of development, 
showed a mosaic pattem of immunofluorescent staining in that they 
contained not only Cl+ FVlll+ cells, but also C l - FVII[ + cells and 
CI+ FVllr ce lls. 
Between 13 and 16 weeks of gestation, m esenchymal cell clusters 
were less numerous as the capillary tubes composed of both cr+ 
and C I- , FVHI-re lated antigen-containing endothelial cells becam e 
more abundant and widely distributed throughout the ECM (Fig 
1D-F). Two diffe rent immunostaining pattems for CI, FVHI-
re lated antigen, and type TV collagen distribution were observed in 
these capillary tubes (Fig 1 G-H). In the predominant pattem seen 
between 14 and 16 weeks of gestation, C I + FVIII - endothelial cells 
w ere found in the distal portion of the e longated capillary tubes. 
Most of the cr+ endothelial cells were in direct contact with tbe 
surrounding ECM . In the e longating portion of these vessels, som e 
of the endothe lial cells were beginning to show early evidence of 
type IV collagen- containing basement m embrane fonnation . These 
elongated capil.lary tubes frequently joined other elongated capil-
lary tubes (Fig 1H). The second vascular pattem was characterized 
by sprout formation from capillary tubes (Fig 1G,H). Sprout 
formation began by the branching out of CI + FVIII - endothelial 
ceiJs, the cytoplasmic processes of which extended long distances 
into the surrounding stroma (Fig 1D,E). These capillary sprouts 
contained C I but stained weakly, or not at all, for FVIH-related 
an tigen and were negative for type TV collagen (Fig 1G,H). Like 
th e elongating vessels, the capillary sprouts were al so in direct 
contact with the ECM. 
At more advan ced stages of gestation (between 22 and 28 
weeks), the vast majority of blood vessels contained CI + FVIll + 
endothelial cells a11d were surrounded by a type IV collagen-
containing basem ent m embrane (not shown). In some blood 
vessels, FVlfl+ endothelial cells were present but CI immunoreac-
tivity was absent. It is inte resting that some smaller capillaries 
contained CI + endothelial cells but stained weakly for FVTII-
related antigen. 
By the 28th week of gestation, most blood vessels were com-
posed of FVIri + endothelial cells lacking Cl. Only a few scattered 
vessels in the de rmis contained CI + endothelial cells. 
Normal Adult Skin h1 all samples of newborn and adult human 
skin studied, FVIII + - staining blood vessels were present through-
out the dermis and were devoid of Cl immunoreactivity. An 
occasional blood vessel in the subcutaneous tissue contained CI+ 
endothelial cells, but no distinc t pattern of vascular staining was 
observed. 
Other Fetal Tissues Virtually the same immunofluorescen t 
pattern of the codistribution of CI , FVlll-related antigen , and type 
IV collagen seen in developing skin was found in feta l stom ach , leg 
muscle, pharynx, lung, and urinary bladder (not shown) . 
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Figure 1. Distribution of CI in blood vessels in developing fetal 
skin. A, fetal skin at 7 weeks of gestation immunostained with anti-C! 
antibody. Immature vascu.lar strands arc positive for Cl (an·outs). Bar, 200 
p..m. B, serial section from the same tissue sample shown in A but at higher 
magnification and stained with anti-FVlli-related antigen. Several of the 
same cr+ endothelial-like cells seen in A are also positive for FV!H-related 
antigen (mwws), whereas other cr+ mesenchymal-like cells are negative for 
FVIIT-related antigen (mww/1ead) . Bar, 113 p..m. C, dermis of fetal skin at 1 0 
weeks of gestation demonstrating that both mesenchymal cell clusters 
(arrowhead) and vascu.lar tubes (an·ows) stain for CI. Bar, 50 J.Lm. D, skin at 
13 weeks of development immunostaincd with anti-C! antibody. Vascular 
tube (arrowh eads) contains cr+ endothelial cells. cr+ c:~pi.l.lary sprouts 
(a rrows) originate from the vascu.lar tube and fonn long cytoplasmic 
processes that extend into the surrounding stroma. Bar, 25 J.Lill. E, the 
identical section shown in D but double stained for Cl (green) and 
FVIII-related antigen {red). Overlap of green and red fluorescence produces 
the yellow color. FVHI + endothelial cells within vascular tubes are also 
Cl+ . Sprouting CJ+ FVUr endothelial cells (an·011's) are readily seen. Bar, 
50 J.Lm. F, skin at 16 weeks of development showing expansion of the 
vascular network from preexisting microvessels by elongation. Double 
immunostaining was used for CI (green) and FVlll-related antigen (red) . 
Elongating vascular tubes (mwws) contain cr+ endothelial cells. The 
vascular tubes extend from a preexisting microvessel containing c r+ FVIIl + 
endothelial cells (an·owheads). Bar, 50 J.Lm. G, skin at 16 weeks of develop-
ment stained with anti-C! :~ntibody. Elongated CI+ vascular tubes (an-ows) 
extend from preexisting vessels (mwwheads) . Bar, 50 J.ttn. H, skin at 16 
weeks of development. Double immunostain.ing w:~s used for type lV 
collagen (red) and Cl (green). Expansion of the vascular network from 
preexisting microvessels is shown by a combination of elongation :~nd 
capillary sprout formation. Preexisting m.icrovcssels are surrounded by a 
type IV collagen-containing basement membrane (an·owlwads). Elongated 
C I + vascular tubes extend from preexisting vessels. Some elongating vessels 
are beginning to show cady evidence of a type lV coHagen-containing 
basement membrane (siuglc am1111s); in others, C l + endothelial cells are in 
direct contact with the surrounding ECM. Sprouting cr+, type IV collagen-
negative (double mTows) endothelial cell s migrate from the tip of the 
elongated portion of the parent vessel and connect directly with other 
microvessels. Bar, 25 J.Lm. 
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Skin Tumors To determine whether the pattern of vascular 
development during embryogenesis was similar to that of neovas-
culari.zation occurring in tumorigenesis, we examined the vascular 
localization of CI in several human cutaneous tumors. The most 
significant finding was that skin tumors con sidered to display more 
aggressive behavior [32 ,3 3] , such as recurrent BCCs, morpheafonn 
BCCs, and SCCs, diH'ered in their vascular patte rn when compared 
with skin tumors displaying less aggressive (noninvasive) features . 
In less aggressive BCCs (e.g., nodular, nodulocystic, keratotic, 
a11d adenoid), FVIII + vessels showed no inununoreactive CI pro-
tein. Examination of recurrent BCCs, morpheaform BCCs, and 
sees showed that the number ofCI+ blood vessels in these tumors 
was significaJ1tly higher than in the less aggressive BCCs. More-
over, the unmwJOstaining patte rn of the vessels in the aggressive 
tumors was clearly diH'erent in that most of the u1dividual blood 
vessels showed a mosaic immw10staining pattern (Fig 2A) simila.r 
to tl1at described above in fetal skin. Capillary elongation [3 4 - 36] 
was the predominant inununostauung pattern found in morphea-
forn1 BCCs, and was also present in the other aggressive tumors 
(Figs 2B-D, 3A). Tlus pattern was characterized by an abundance 
of extended, narrow, CI+ tube-like vascular structures (Figs 
2B-D, 3A,B) that were virtually identical to their counterpart u1 
fetal tissues . As clearly shown in Fig 3A,B, the elongated portions 
of the microvessels were positive for CI (Fig 3A) but negative for 
FVIII-related antigen (Fig 3B). Immunostain.ing was absent in 
tissue sections treated with nonimmune rabbit IgG followed by 
inm1unostaini.ng with the second anti-rabbit FITC-labeled antibody 
(Fig 3C). These Cl+ tube-like vessels pene trated tl1e tumor nests 
and were localized between the tumor cells (Figs 2D, 3D). 
Immunostaining witl1 aJlti-gelatinase B (92T4CI) antibody (Figs 
2E, 3E) showed the presen ce of this enzyme within polymorpho-
nuclear leukocytes close to the tumor n ests. Immunoreactivity to 
gelatinase B was absent in the cr+ -staining microvessels and their 
associated stroma (Figs 2E, 3B). M atrilysin protein, as we have 
shown previously [28], was localized only within the tun1or cells 
(Fig 3F), whereas immwJOreactivity for strom elysin was found 
both extracellularly and Ul 'the stromal fibroblastic cells (Fig 3G). 
Specific staining was not observed in tissue sections incubated only 
\vith the second bioti.nylated a11ti-rabbit complex followed by 
incubation with extravidin-FITC-labeled antibody (Fig 3H). 
Capillary sprouting [37-39] was also greatly u1creased in tl1e 
aggressive skin tumors. These sprouting CI+ FVIII- endothelial 
cells revealed a decreased u1tensity of inm1unostaining for type IV 
collagen compared with elongated CI + FVIII- blood vesse ls that 
were surrounded by a basement membrane. The capillary sprouts 
were often interconnected when close to tl1e parent vessel or tumor 
nests (Fig 2B,F) , unlike the elongated vessels, which formed 
commwucations at long distances from the parent vessel (Figs 
2C,D, 3D). In addition, at the tips of the elongated vascular tubes , 
short arrays of sprouting Cl+ FVIII - and type IV collagen-negative 
endothelial cells were seen extending toward the tumor nests (Fig 
2F) or jou1.U1g adjacent blood vessels (Fig 2B). Thus, neovascular-
ization U1 aggressive tumors was characterized by both elongating 
and sprouting CI-containing vessels in direct association with the 
ECM, which is also a characteristic of developing blood vessels in 
fetal skin. No correlation was found ben veen the presence of c r+ 
blood vessels and the inflammatory cells that are known to infiltrate 
the ECM of these tumors [28]. 
In Figs 2E and 3D-H, w e show u1 the same tissue sections that 
specific inunw10fluorescent stauung failed to detect stromelysin, 
gelatinase A and B, or matrilysu1 in fetal skin or tumor blood 
vessels. However, most of these enzym es were readily localized 
[28, 29] to the tumor and/or to the surrow1ciing stromal cells (Figs 
2E, 3D-H). Tlus suggests that only vaiuslungly small quantities of 
these enzymes could escape detection. 
DISCUSSION 
Both normal tissue development and tumor growth and metastasis 
are dependent ou active an giogenesis. 111' vitro studies led to the 
proposition that ECM m etalloproteinases play an important role in 
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Figure 2. Enzyme itnmunoreactivity in blood vessels of cutaneous 
t umors. A, mosaic pattern of staining for C l and FV III-related antigen in 
a tumor blood vesse l. Double immunoflu orescent sta ining was used for C l 
(green) and FVTn (red). Overl ap of green and red fl uorescence produces the 
yellow color. T he vessel is lined with C l + FVI II + endothelial cell s 
(mTowheads), C l+ Fvm - endothelial cells (tlou l>le am>ws), and C l- FV III + 
endotheli al cells (asterisk) . Early cap ill ary sprouting of C I + endothelial cell s 
(s iugle a/WillS) from the parent vessel can be seen. Bar, 50 /l-nl . B, sec with 
double staining for C l (green) and type IV collagen (red). CI + , type LV 
coll agen-negative capillar y sprout (siuglc mmw) arises from a C I+ FVILI + 
parent microvessel surrounded by a type IV co ll agen-containing basement 
m embrane (do uble a>mw). Two Cl + endothelial cells arc seen extending 
from the wall of a parent micro vessel by elongation (mTouJ/wmls) and show 
early cv.idencc of a type IV coll agen-containing basement membrane. Bar, 
25 J.Lm . C , recurrent BCC wti h double immunosta in ing for C I (green) and 
cytokeratin 17 {red) , which stains the tumor nests (T). Many elongated C l+ 
vascular tubes (an·ows) arc seen in the tumor stroma . *T he area shown at 
higher magnifi ca tion in E. Bar, 200 /l-In. D. recurren t BCC with do uble 
immunosta.ining for C l (green) and cytokeratin 17 (red). C l+ vascular tubes 
(mmws) penetrate the tumor nest (T) and arc loca lized between the tumor 
cells. Bar, 50 /l-m. E, se rial section from recurrent l3CC shown in C (ast erisk) 
stained with anti-gclatinasc B (92T4C l) antibody. T he enzyme is localized 
within stromal polymorphonuclear leukocytes (anows). It is absent in 
endothe li al cells and in the surrounding microvascular stron1a. T, ttunor 
nest . Bar, 50 /l-ITI . F, SCC with do uble immunosta ining for C J (green) and 
type IV coll agen (red). Cl + but type IV collagen-negative capilla ry sprout 
(mwws) is seen developing from a C I+ parent vessel (arrowhead) tha t is 
surrounded by type IV collagen. T he capillary sprout extends through the 
ECM toward the tu mor nest (T). Bar, 100 /l-ITI . 
angiogenesis by fac ilitatin g endoth e lial ce ll migration thro ugh the 
ECM [3-5,7,10-12,40]. Generally, synthesis of secreted ECM 
metalloprotcinases is regulated in tissues in response to both the 
organizational state and the nature of the resident ce ll s in t h e ECM . 
T hus, both the repertoire and th e level of en zym e expression by 
cell s c ultu red i11 vitro diffe r dramati.ca lly from those o b served i11 11i11o. 
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Figure 3. Immunofluorescent localization of MMPs in SCCs. A, 
SCC immunostained with anti-C! antibody. Elongation occurs fro m the tip 
of a microvesscl (doul>le mm111s). C l+ endothelial cells are seen extending 
fro m the parent vessel (siugle arrows). Bnr, 70 ,_,m . B, the identical section as 
shown in A double sta ined with anti-FVI!I-relatcd antigen. FVJfl-relatcd 
antigen is absent fro m the elongated C l+ portio n of the microvessd (double 
arro111s) . Numerous C l - but FVJII + microvessels arc seen in the tumor 
stroma (si11_gle mmws). Bar, 70 /l-m. C, serial section control for A and B 
incubated with nonimmune rabbit lgG followed by immunostaining with 
anti-rabbit FITC-labeled antibody. No specific immunoreactivity is present 
in the endothelial ce ll s of micro vessels (arrows) within the tumor ECM. Bar, 
70 p.m. D , SCC immunostained for anti-C ! antibody. Expansion of the 
n1icrovascular cord-like network from preexisting n1icrovessels is sitnilar to 
that seen in developing feta l tissues (arrows) . T, tun1or nests; *, stron1a. Bnr, 
50 ,_,m. E, serial section from D stained with anti-ge latinase B (92T4Cl) 
antibody. T he majority of enzyme is present within extravascular polymor-
phonuclear leukocytes (an-mvs) in the tumor stroma (sec (29]). T , tumor 
nest. Bar, 50 ,_,m. F, serial section from D stained for matrilysin. Enzyme is 
present w ithin the tumor cells (arro111s) (sec (28]). N o immunoreactivity was 
seen in the vesse ls o r stroma (asterisk). T, tumor nest. Bar, 50 ,_,m . G, serial 
section fro m D stained with antibody for stromclysin . Stromelysin immu-
noreactivity i.s found both extracellularly and in the stromal fibroblastic cells 
(mm111s) but is no t present in microvascular endothelial cells. T, tumor nest. 
Bar, 50 ,_,m. H, serial section from D incubated with tbe second biotinylated 
anti-rabbi t complex fo llowed by incubation with cxtravidin-F!TC-Iabeled 
antibody . Specific immunolabeling for these antibodies is absent. T , tumor 
nest; asterisk, stro nut. 13nr, 50 J.tm . 
T his consideration makes the i11. sil 11 detection of en zym es present 
during tissue remode ling n ecessary to d e termine the specific role of 
each protease in su ch a process. In ti ssue culture, endothelial cells 
h ave been sh own to produ ce signifi cant amounts of CI, stromely-
sin , and gela t inase A and B [3- 5,7,10-12,19,20,40]. Our data show 
that C l , and not other MMPs, can be d etec ted in fetal and tumor 
blood vessels. T h ese findings are consistent with the h ypothesis that 
------------------------~~~~~~----~--~-----~~--------~--------~--------------~--------~ 
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cr+ endothelial cells play a role in proteolytic degradation of the 
ECM that occurs in new blood vesse l formation and promote 
endothe l.i al ce ll migration through the ECM (3-5 , 1 0 - 12,40]. 
Th.is study shows that a major feature of anJ,>iogenes is in both 
fetal and tumor tissue is the presence of an extensive network of 
branching, sprouting, and anastomosing capill ary-Like tubular 
structures (34-39] composed of C t+ end othelial cells. T he pres-
ence of endothe l.i al cell CI in the developing vasculature suggests 
that this meta ll oproteinase may be involved in two morphogenetic 
processes of vascular development in fetal tissue: vasculogenesis, or 
de 110110 blood vessel fonnation fi.·om undifferentiated mesodenn 
[30,31] , and angiogenesis , o r new blood vesse l formation from the 
existing vascu lar network (34-39]. Although the precise mecha-
nisms for these two morphogenetic processes are unknown, several 
steps in this complex series of events have been proposed . These 
include endothe lial cell migration, capillary budding, estab l.i shment 
of capillary !.oops, and neovascular remodeling of already existing 
vessels [34-39] . The observations presented here emp has ize the 
irnrnunophenotype of Cl-conta ining endothelial ce Ll s present in 
both elongated and sprouting microvessels. 
Capillary development in early embryonic skin is represented by 
clusters and solid cords of m osa ic-staining (Cf+ FVIII + , C l + 
FVIII- , and C J- FVIII +) endothe lial cells. T hese cords differenti-
ate into tube-like cap ill at;es [30,31 ], the endothelial cells of w hich 
retain th.is mosaic immunostaining pattern. T he mosaic staining 
pattern fo r both C I and FVfll-related antigen in presumptive 
vascular tubes was first seen in fetal dermis between 12 and 16 
weeks of gestation. This may reflect the different potentials of 
endothel.ial cells in the fom1ation of new blood vessels by capilla ry 
elongation and capillary sprout formation (37-39]. 
As shown in Fig 4, new blood vesse l formation is characterized 
by capillary e longation and capillary spro ut formation from preex-
isting capillary tubes [33-38]. Our data show that C<tpiJiary tubes are 
composed of both c r+ FVIII + and C I- FVIII + endothelial ce lls 
and arc sunounded by type fV collagen (Fig 4A a,a', B ll,a'). As 
the C<tpiiJary tubes e longate, their dista l portions contain only C l + 
FVIII- , type IV co!J agen-ncgativc endothelial cells. Most Crl-
endotheliaJ ce!Js are in direct contact with the surrounding ECM 
(Fig 4B b,b') . A few e.longating vessels then begin to show early 
evidence of a type IV co!Jagen-containing basement membrane. 
From some of these capillary tubes, sprout formation begins by the 
bran clung out of C l + FVIIL - cytoplasmic processes (Fig 4A l1,b', 
A c, B c,c'). T hese processes often extend long distan ces into the 
surrounding stroma. Capillary sprouts conta in C I but sta in weakly 
or not at all for FVIII-rclated antigen and for type IV collagen. In 
addition , single sprouting endothelial ce lls form C l + FV!II - vas-
cular ring-Hkc structures lacking type IV collagen and resembling a 
capillary lum en in cross-section (Fig 4B d). C hanges in the strom al 
composition of the fetal dennis from a predominant cellular to a 
fibro us dermis may play an important role in the o rganization of the 
vascular network from discrete, discontinuous , mesenchymal ce!J 
clusters into e longated tube-Like structures [41]. It is in this process 
of e longation and sprouting of fetal vesse ls thro ugh the fibrous 
stroma that co Ll agenase may play an important role in loca lized 
ECM turnover. 
Investigation of skin tumors showed that in BCCs characterized 
by less aggress ive behavior, cr+ immunoreactivity was rarely seen 
in blood vessels. In contrast, cutaneous tumors that exhibited 
featu res of more aggressive [32,33] or invasive behavior (morphea-
form and recurrent BCCs, and SCCs) were characted zed by 
numerous groups of intercormected C I-contain.ing microvessels. 
These blood vesse ls showed a mosaic pattern ofimmunosta.ining for 
Cl and FV III-re lated antigen. It is these vesse ls that arc most Likely 
involved in angiogenesis during tumor growth. T he absence of 
neovascu lari zation is known to restrict markedly the size of a tumor 
mass [42,43] . lf neovascularization occurs, the onset of angiogenic 
activity allows rapid expansion of the tumor ( 43]. In breast cancer, 
for example, the likelihood of metastasis increases as the microves-
sel density in creases in the area of most intense neovascula rization 
[ 42]. T his was not the case for the skin tumors studied here in 
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Figure 4. Schematic representation of the localization of CI dur-
ing blood vessel formation by two distinct but related mechanisms. 
Mechanisms arc by capi ll ary sprouting and by a combination of elongation 
and capi ll ary sprouting from preexisting vessels. A , I , sprouting Cl + FV III -
endothclial ce lls (dnrk color) devoid of a basemen t membrane become 
organized into solid cords that migrate from adjacent parent vesse ls. As the 
Cl + FVJII - cells within the co rds begin to migrate (n ,n') those arising from 
the wa ll of the parent vesse l (2) begin to express FV II1-rclated antigen 
(stripes) and arc now surrounded by rype IV collage n (dots; b,b' ). The most 
distal Cl + FVJII - endothelia l cells , which lack type IV coll agen (J) fuse to 
fonn a con1n1unicating vessel (d). This comn1unicating vessel shows CJ + 
FVIII + endothelial cell s (stripes) and C l- FVIII + endothelial cells (utltitr). 
T he blood vessel is now complete ly surrounded by a type IV coUagen-
contain.ing bascn1c nt· n1C111bra.ne (dots). B. expansion of the vascular ncn:vork 
from preexisting vesse ls by a combination of elongation and capillary sprout 
formation . Preexisting parent vessel (n,n') consists of C l - FV JII + endothe-
lial cells (fllltilc w lor) and is surrounded by a basem ent membrane (dots). In 
a portion of the vessel wall (mwfiJs), FVI II + endothelial ce lls begin to 
express C l (stripes). E longation proceeds (b,b') !Tom C l + cells, which no 
longer sta in for FV III-related antigen (dnrk color) and stain only weakly or 
not at aU for type IV collagen. From the tip of the elongated portion of the 
parent vessel, capillary sprouts form cytoplasm ic processes devoid of a 
basement membrane. These C l + FVlll - capillary sprouts may connect 
directly with a newly formed vessel (d), communicate with the elongating 
portion of another preexisting blood vesse l (c), or, in the case of tumor 
ncovascularization. extend into the adj acen t tumor nes t(/}. 
which the rate of metastasis was low, but in the more aggressive 
BCCs, tumo r neovascularization was often associated with exten-
sive local invasion. 
In tumors, as in fetal angiogenesis, vascular immunostaining 
patterns for CT and FV III-rclatcd antigen were characterized by 
e longation and cap illary sprout formation, primadly from the blood 
vessels showing a mosaic immunostaining pattem for CI. Expansion 
of the tum o r vascular nenvork fi-om preexisting vessels could be the 
res ult of a combination of e longation and capill ary sprouting of C I + 
FVIII - endothel.ial cells, particularly from the tips of the elongated 
portions of parent vessels in which a surrounding type IV collagen-
containing basement membrane is absent [34 - 39]. 
Sprouting blood vesse ls predominated in the stroma of recurrent 
BCCs and ofSCCs, but elongation from existing blood vessels was 
seen more often in the fibrous stroma of morpheaform BCCs. 
T hese findings suggest that the collagenous matrLx loses its struc-
tural organization at limited sites adjacent to cr'· migrating endo-
thcl.ial cells, all owing the growth of vascular endothelium by 
e longatio n and capiLla ry sprouting. T he C r '· FVTIT- and type IV 
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collagen-negative cap illary sprouts present in the tumor strom a 
were identical to those seen in fetal angiogenesis. ln add ition, in the 
aggressive tumors, the capillary sprouts formed cords of c r+ 
FVIH- endotheli al cell s that were simi lar to the solid cords of 
endothelial cells around presumptive vessels seen in feta l ski11 
between 14 and 16 weeks of development (Fig 4) . T hese cords of 
endothelial cells often extended into adja cen t tumor nests (Fig 4) . 
Our observations show that capillary spm uting by the migration 
of endothel ial cells fi:om the parent vessel may result in the transient 
switchi ng off of FVIH-related antigen expression. T l:ti s is supported 
by the finding that migrating Cl-containing endothe lial cell s did not 
stain fo r FVIII-re lated antigen . In addition, these endothelial cells 
lacked a type IV collagen-containing basement membra ne . T his 
suggests that the exp ression of FVIII-related antigen is substrate 
dependent and reA ects the level of e ndothelial ce ll d ifferen tiatio n 
during development of the vascular system. 
T he present study shows a clear association between angiogen-
esis [34-39) and the presence of CI in endotheli al cells. Microvas-
cular endothelial cells may escape from the parent vessel by sprou t 
formation. Vascular sprouts are CJ + bu t do not contain a surround-
ing basement membran e. C l-containing endothelial cells are in 
direct contact w ith ECM macromolecules, and localized proteolysis 
may fac ili tate e ndothelial cell migration . It is possible, although 
highl y unli ke ly, that the amo unt of basement-membrane-degrad-
ing enzymes in newly formed blood vessels is beyond the sensitivi ty 
of the immunocytochemica l techn iques used. CI-re lated degrada-
tion of ECM interstitia l collagens can o nl y be proposed for elon-
gating and sprouting, cr'· endothelial cells that have obtained 
direct access to the ECM. Although C l activity can be modulated 
by TIMPs [9,13 ,16,18,23-26), the impo rtance of T lMPs in the 
regu lation of C J in the perivascular space is unknown. 
It is evident from our studies of both feta l and tumo r angiogenesis 
that the•·e may not be a direct corre latio n between endothelial cell 
be havior ilt 11 i 11o and iu. 11ilro. Endothelial cells m ay be stimulated itt 
vitro by agents s t~ch as phorbol myristatc acetate [1 0,11] and 
lam inin-det·ivcd A-chain peptide [6] to produce a variety of ECM 
m eta ll oproteinases in association with an angiogenesis-like pattem. 
However, the angiogenic stimuli responsible for the proteolytic 
events during itt 11i11o angiogenesis appear to be quite different. As a 
resu lt, Cl was the predominant ECM metalloproteinase present in 
endothelia l ce ll s engaged in new vessel fo rmatio n. Altho ugh the 
presence of relatively small q uantities of other m etalloproteinases 
ca1mot be excl uded completely . immunoAuorescen t sta ini ng 
showed no ev idence of stromelysin , matrilysin , or the gelatinases in 
en doth eli al cells d uring embryogenesis or tumor neovasculariza-
ti.o n . However, gelatinase B, matrilysin, and stromelysin were 
fotU1d in the sa m e tissue sections but locali zed to different cell types. 
Although minor quantities of the other metalloproteinases re-
mained undetected, the results presented here suggest that C l is 
exploited by migrating endothelial cells to in vade the surro und in g 
ECM during blood vessel deve lopment. 
Wt• tlwuk C iuger Rol>errs )or prepnratiou ~f tllis uwuuscript. T J. is study wns 
supported 1>)' Nnt iounl /u stitutcs of f-lcnltlt grau/s AR 12 129, AR 07284, A I{ 
39472, n111l AR 40618, aud !J)' tile Mousnuto Couipnuyl l,Vnsltiugto u Uui11crsity 
Researclt Agn:emelll . 
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